Logo-npj

Epidemiology and Prevention

1. Drug therapy in hospitalized patients with very severe symptoms following COVID-19
Rohollah Valizadeh ORCID, Nahid Dadashzadeh, Roya Zakeri, Steven James Kellner ORCID, Mohsen Mohammad Rahimi* ORCID
J Nephropharmacol. 2020;9(2): e21. doi: 10.34172/npj.2020.21
Scopus ID: 85085256177    
Article
PDF
XML
Cited By:
20
7
Review

2. Perspectives on the relationship of renal disease and coronavirus disease 2019
Banafsheh Yalameha ORCID, Bijan Roshan ORCID, Lakkakula VKS Bhaskar ORCID, Leila Mohmoodnia* ORCID
J Nephropharmacol. 2020;9(2): e22. doi: 10.34172/npj.2020.22
Scopus ID: 85085931964    
Article
PDF
XML
Cited By:
18
19
Mini-Review

3. Covid-19 and kidney; a mini-review on current concepts and new data
Elaheh Keivani Boroujeni ORCID, Steven James Kellner ORCID, Aiyoub Pezeshgi* ORCID
J Nephropharmacol. 2021;10(1): e01. doi: 10.34172/npj.2021.01
Scopus ID: 85090653016    
Article
PDF
XML
Cited By:
6
4
Perspective

4. Lessons of mortality following COVID-19 epidemic in the United States especially in the geriatrics
Majid Daneshfar ORCID, Nahid Dadashzadeh ORCID, Mohammad Ahmadpour ORCID, Hedieh Ragati Haghi, Vahid Rahmani ORCID, Mehdi Frouzesh* ORCID, Rohollah Valizadeh ORCID
J Nephropharmacol. 2021;10(1): e06. doi: 10.34172/npj.2021.06
Scopus ID: 85090667013    
Article
PDF
XML
Cited By:
22
14
News and Views

5. Glomerulonephritis associated with SARS-CoV-2 infection
Mohsen Akhavan Sepahi* ORCID, Bhaskar VKS Lakkakula ORCID, Bijan Roshan ORCID, Banafsheh Yalameha ORCID
J Nephropharmacol. 2021;10(1): e07. doi: 10.34172/npj.2021.07
Scopus ID: 85090690110    
Article
PDF
XML
Cited By:
0
0
Epidemiology and Prevention

6. New hope for treatment of respiratory involvement following COVID-19 by bromhexine
Abdolrazagh Barzegar ORCID, Masoud Ghadipasha ORCID, Nima Rezaei ORCID, Mehdi Forouzesh* ORCID, Rohollah Valizadeh ORCID
J Nephropharmacol. 2021;10(2): e11. doi: 10.34172/npj.2021.11
Scopus ID: 85111460184    
Article
PDF
XML
Cited By:
19
12

Mini Review

7. Strive for kidney health for everyone during COVID-19; the possible theme for the world kidney day 2021
Elahe Aleebrahim-Dehkordi ORCID, Elaheh Mazaheri ORCID, Bijan Roshan ORCID, Bhaskar VKS Lakkakula ORCID, Ali Hasanpour-Dehkordi*, Maryam Khosravian ORCID, Aiyoub Pezeshgi* ORCID
J Nephropharmacol. 2021;10(2): e12. doi: 10.34172/npj.2021.12
Scopus ID: 85111439886    
Article
PDF
XML
Cited By:
2
1

Review

8. Herbal medicines in the treatment of coronavirus disease 2019 (COVID-19)

Audrey Tolouian ORCID, Maryam Khosravian ORCID, Hedieh Ragati Haghi, Alireza Bolourian, Zahra Mojtahedi ORCID, Masoumeh Asgharpour* ORCID, Amirhesam Alirezaei* ORCID
J Nephropharmacol. 2021;10(2): e18. doi: 10.34172/npj.2021.18
Scopus ID: 85111447453    
Article
PDF
XML
Cited By:
2
1
Mini Review

9. Understanding kidney injury in COVID-19; a pressing priority
Elham Ahmadipour, Bhaskar VKS Lakkakula ORCID, Golnaz Vahdani ORCID, Ramin Tolouian ORCID, Hedieh Ragati Haghi ORCID, Doris Delgado ORCID, Luiz Augusto Fernandes da Silva, Masoud Hafizi* ORCID
J Nephropharmacol. 2021;10(2): e19. doi: 10.34172/npj.2021.19
Scopus ID: 85111446934    
Article
PDF
XML
Cited By:
0
0
Review

10. Kidney complications following COVID-19 vaccination; a review of the literature

Shakiba Hassanzadeh ORCID, Arjang Djamali ORCID, Leila Mostafavi ORCID, Aiyoub Pezeshgi* ORCID
J Nephropharmacol. 2022;11(1): e1. doi: 10.34172/npj.2022.01
Scopus ID: 85119343454    
Article
PDF
XML
Cited By:
3
4

News and Views

11. Exacerbation of an undiagnosed pre-existing lupus nephritis following an inactivated COVID-19 vaccination

Shakiba Hassanzadeh ORCID, Muhammed Mubarak ORCID, Mohsen Akhavan Sepahi* ORCID, Hamid Nasri* ORCID
J Nephropharmacol. 2022;11(1): e2. doi: 10.34172/npj.2022.02
Scopus ID: 85119605257    
Article
PDF
XML
Cited By:
2
0

Case Report

12. Acquired hemophilia in a patient with SARS-CoV-2 infection; a case report
Ali Hajigholami* ORCID, Hourieh Ansari ORCID, Sakineh Ansari ORCID, Shakiba Hassanzadeh ORCID
J Nephropharmacol. 2022;11(2): e10453. doi: 10.34172/npj.2022.10453
Scopus ID: 85134163055    
Article
PDF
XML
Cited By:
1
2

Case Report

13. COVID-19-associated thrombotic thrombocytopenic purpura (TTP); a case report
Ali Hajigholami* ORCID, Hourieh Ansari ORCID, Sakineh Ansari ORCID, Shakiba Hassanzadeh ORCID
J Nephropharmacol. 2023;12(1): e10454. doi: 10.34172/npj.2022.10454
Scopus ID: 85146749813    
Article
PDF
XML
Cited By:
0
0

Case Report

14. Acute myocarditis and acute myopathy as the first manifestations of COVID-19; a case report
Fatemeh Yaghoubi ORCID, Farnaz Tavakoli* ORCID, Fatemeh Ghanbari ORCID, Nasser Aghdami ORCID, Davood Babakhani ORCID
J Nephropharmacol. 2023;12(1): e10479. doi: 10.34172/npj.2022.10479
Scopus ID: 85146904300    
Article
PDF
XML
Cited By:
0
0
Letter to Editor

15. Hope and fear; Paxlovid for COVID-19 treatment: A Letter to the Editor

Alireza Pouramini ORCID, Maryam Khosravian ORCID, Fatemeh Kafi ORCID, Sina Bakhshaei ORCID, Hamid Reza Jahantigh ORCID, Payam Peymani ORCID, Neda Kianpour ORCID, Majid Foroutan* ORCID
J Nephropharmacol. 2022;11(2): e10485. doi: 10.34172/npj.2022.10485
Scopus ID: 85134148876    
Article
PDF
XML
Cited By:
0
0
News and Views

16. Nirmatrelvir, a novel medication for COVID-19 treatment
Mohammad Reza Hajian ORCID, Hamid Reza Jahantigh ORCID, Shahrzad Alimohammadi ORCID, Zahra Mojtahedi ORCID, Neda Kianpour ORCID, Majid Foroutan* ORCID
J Nephropharmacol. 2023;12(1): e10486. doi: 10.34172/npj.2022.10486
Scopus ID: 85146747296    
Article
PDF
XML
Cited By:
0
0
Original

17. A study on the effect of aspirin on clinical symptoms, laboratory indices, and outcomes in patients with COVID-19

Roham Azizi ORCID, Maryam Dehghani Mobarakeh ORCID, Reza Goujani ORCID, Mohsen Nabi-Afjadi ORCID, Soheil Mousavi Rizi ORCID, Ahmadreza Maghsoudi* ORCID
J Nephropharmacol. 2023;12(2): e10506. doi: 10.34172/npj.2023.10506
Scopus ID: 85162014634    
Article
PDF
XML
Cited By:
0
1
Case Report

18. Arrhythmia in a COVID-19 patient: A case report
Amir Aria ORCID, Faezeh Tabesh ORCID, Maryam Soheilipour ORCID, Elham Tabesh ORCID, Mehrnoush Dianatkhah ORCID, Morteza Pourahmad, Mahnaz Momenzadeh* ORCID
J Nephropharmacol. 2023;12(2): e10510. doi: 10.34172/npj.2023.10510
Scopus ID: 85161809172    
Article
PDF
XML
Cited By:
0
1
Review

19. Systemic lupus erythematosus following SARS-CoV-2 vaccination; a review of literature
Leila Mahmoudnia ORCID, Bijan Roshan ORCID, Hamid Reza Jahantigh ORCID, Zahra Mojtahedi, Oscar F Borja Montes, Tella Sadighpour ORCID, Mohammadreza Khosravifarsani* ORCID
J Nephropharmacol. 2023;12(1): e10564. doi: 10.34172/npj.2022.10564
Scopus ID: 85146786414    
Article
PDF
XML
Cited By:
0
1
Original

20. Effectiveness of corticosteroid therapy in patients with moderate to severe coronavirus disease 2019: a retrospective study

Sara Sadeghi ORCID, Marjan Mansourian ORCID, Sara Ebrahimi, Baran Kahid Basiri ORCID, Niloofar Nikgoftar ORCID, Soheila Jalali ORCID, Ramin Sami* ORCID
J Nephropharmacol. 2023;12(2): e10577. doi: 10.34172/npj.2023.10577
Scopus ID: 85162068753    
Article
PDF
XML
Cited By:
0
0
Clinical Trial

21. The effect of adding ivermectin to the standard COVID-19 treatment in intubated patients
Reza Baghbanian ORCID, Mohsen Savaie* ORCID, Farhad Soltani ORCID, Mahbobeh Rashidi ORCID, Mehrdad Dargahi MalAmir ORCID, Fereshteh Amiri ORCID, Nima Bakhtiari ORCID
J Nephropharmacol. 2023;12(2): e10589. doi: 10.34172/npj.2023.10589
Scopus ID: 85162132129    
Article
PDF
XML
Cited By:
0
0
Original

22. Immunity due to COVID-19 vaccination and its correlation with lung involvement severity as an indicator of disease severity
Razieh Mousapour ORCID, Mostafa Assarroudi ORCID, Yaser Khanchemehr ORCID, Masoomeh Mehrbarjou ORCID, Golmis Abdolmohammadi ORCID, Farshad Gharebakhshi ORCID, Erfan Ghanbarzadeh ORCID, Hussein Soleimantabar* ORCID
J Nephropharmacol. 2023;12(2): e10591. doi: 10.34172/npj.2023.10591
Scopus ID: 85163074426    
Article
PDF
XML
Cited By:
0
0
Mini-Review

23. Cancer recurrence or aggravation following COVID-19 vaccination
Parisa Soleimani ORCID, Sepideh Yadollahifarsani ORCID, Mahsa Motieian ORCID, Mahshid Sadat Chenarani Moghadam ORCID, Shahrzad Alimohammadi ORCID, Azadeh Khayyat ORCID, Mohammad Ali Esmaeil Pour ORCID, Sina Neshat ORCID, Narges Alsadat Marashi ORCID, Leila Mahmoodnia* ORCID, Rohollah Masomi* ORCID
J Nephropharmacol. 2023;12(2): e10593. doi: 10.34172/npj.2023.10593
Scopus ID: 85161801228    
Article
PDF
XML
Cited By:
0
0
Clinical Trial

24. Evaluation of the effect of montelukast drug in improving the clinical condition of patients with COVID-19 in referral hospitals in Isfahan; a randomized clinical trial
Morteza Pourahmad ORCID, Amir Aria ORCID, Mahnaz Momenzadeh* ORCID, Fatemeh Nikoukar, Behrooz Ataei, Farzin Khorvash ORCID, Manizhe Shams, Kiana Shahzamani ORCID, Sara Nasirharandi
J Nephropharmacol. 2024;13(2): e11650. doi: 10.34172/npj.2023.11650
Article
PDF
XML
Cited By:
0
Case Series

25. Severe respiratory acidosis contributing to refractory hyperkalemia: a case series of COVID-19 patients with renal failure
Nabadwip Pathak* ORCID, Sunil Kumar Nanda ORCID
J Nephropharmacol. 2024;13(2): e11684. doi: 10.34172/npj.2024.11684
Article
PDF
XML
Cited By:
0